1. Home
  2. MBIN vs GHRS Comparison

MBIN vs GHRS Comparison

Compare MBIN & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merchants Bancorp

MBIN

Merchants Bancorp

N/A

Current Price

$49.51

Market Cap

2.3B

Sector

Finance

ML Signal

N/A

Logo GH Research PLC

GHRS

GH Research PLC

N/A

Current Price

$17.49

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MBIN
GHRS
Founded
1990
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MBIN
GHRS
Price
$49.51
$17.49
Analyst Decision
Hold
Strong Buy
Analyst Count
3
10
Target Price
★ $67.00
$42.44
AVG Volume (30 Days)
115.6K
★ 333.3K
Earning Date
10-28-2026
11-13-2026
Dividend Yield
★ 0.88%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 4.79
N/A
Revenue
N/A
N/A
Revenue This Year
$10.52
N/A
Revenue Next Year
$3.15
N/A
P/E Ratio
$10.44
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.95
$12.04
52 Week High
$56.87
$31.44

Technical Indicators

Market Signals
Indicator
MBIN
GHRS
Relative Strength Index (RSI) 39.73 34.73
Support Level $47.81 $14.36
Resistance Level $51.01 $22.51
Average True Range (ATR) 1.40 1.29
MACD -0.36 0.00
Stochastic Oscillator 3.97 7.44

Price Performance

Historical Comparison
MBIN
GHRS

About MBIN Merchants Bancorp

Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: